newsfilter
← Latest News
GlobeNewswire·

Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026

  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026.
  • CEO Adrian Gottschalk will present a fireside chat on Tuesday, June 9, 2026, at 1:20 p.m. EDT.
  • Management will also conduct one-on-one meetings during the conference.
  • The company's Gene Traffic Control platform focuses on correcting abnormal gene expression within the chromatin regulatory system to treat diseases, with an initial oncology focus.
  • A webcast of the fireside chat will be available for 90 days in the "Events & Presentations" section of the company website.